Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classification.

MLA

Deng, Maximilian Y., et al. “Analysis of Recurrence Probability Following Radiotherapy in Patients with CNS WHO Grade 2 Meningioma Using Integrated Molecular-Morphologic Classification.” Neuro-Oncology Advances, vol. 5, no. 1, May 2023, p. vdad059. EBSCOhost, https://doi.org/10.1093/noajnl/vdad059.

APA

Deng, M. Y., Hinz, F., Maas, S. L. N., Anil, G., Sievers, P., Conde-Lopez, C., Lischalk, J., Rauh, S., Eichkorn, T., Regnery, S., Bauer, L., Held, T., Meixner, E., Lang, K., Hörner-Rieber, J., Herfarth, K., Jones, D., Pfister, S. M., Jungk, C., … König, L. (2023). Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classification. Neuro-Oncology Advances, 5(1), vdad059. https://doi.org/10.1093/noajnl/vdad059

Chicago

Deng, Maximilian Y, Felix Hinz, Sybren L N Maas, Günes Anil, Philipp Sievers, Cristina Conde-Lopez, Jonathan Lischalk, et al. 2023. “Analysis of Recurrence Probability Following Radiotherapy in Patients with CNS WHO Grade 2 Meningioma Using Integrated Molecular-Morphologic Classification.” Neuro-Oncology Advances 5 (1): vdad059. doi:10.1093/noajnl/vdad059.